Pricing Log in Create free account

Entera Bio Ltd. (ENTX) vs Prothena Corporation plc (PRTA)

Entera Bio Ltd. and Prothena Corporation plc are both Biotechnology companies. Entera Bio Ltd. and Prothena Corporation plc are of similar size ($462.4M and $453.8M). Prothena Corporation plc grew revenue faster over the last twelve months: 427.3% against 66.4%. Entera Bio Ltd. has the higher net margin (0.00% vs −80.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Prothena Corporation plc leads on 10 and Entera Bio Ltd. on 6.

Valuation

Metric ENTX PRTA Biotechnology median
P/E n/m n/m 8.56
P/S 599.53 8.06 10.17
P/B 18.40 1.53 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 534.34 2.78 9.64
Earnings yield (13.21%) (9.85%) (29.41%)
Free cash flow yield (8.22%) (13.83%) (23.50%)

Profitability

Metric ENTX PRTA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (101.80%) 0.00%
Net margin 0.00% (80.67%) 0.00%
Free cash flow margin 0.00% (111.49%) 0.00%
Return on equity (138.92%) (14.39%) (56.66%)
Return on assets (87.02%) (12.54%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTX PRTA Biotechnology median
Revenue growth (TTM) 66.42% 427.32% 5.64%
EPS growth (last fiscal year) 0.00% (99.56%) 30.08%
Revenue growth, 5-year CAGR (29.19%) 62.56% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 25.05 4.72
Net debt to EBITDA 1.29 1.46 0.96

Dividend

Metric ENTX PRTA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ENTX PRTA Biotechnology median
Market cap 462.40m 453.82m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack